Dubai: The Ministry of Health and Prevention (MoHAP) in UAE has issued a decision to withdraw and suspend the registration of all batches of two pharmaceutical products: Proton 40 mg and Proton 20 mg EC tablets.
The Proton brand was manufactured by the Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO), and used to treat heartburn by reducing the amount of acid made in the stomach.
The move was based on the warning issued by the Saudi Food and Drug Authority on March 12, 2021.
In a circular, the ministry pointed out that the withdrawal of the two products were earlier issued by the Gulf Health Council due to the medicine’s “non-bio equivalence to the reference product”, which was registered with the Drug Administration at the Ministry of Health.
«الصحة» تسحب دواءين شهيرين لعلاج حرقة المعدة albayan.ae - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from albayan.ae Daily Mail and Mail on Sunday newspapers.